American Transplant Congress

25 articles about American Transplant Congress

• Hansa Biopharma Interim Report January-June 2019

  7/18/2019

  Imlifidase benefits highlighted in recent ATC presentations. Expansion outside transplantation with initiation of study in Guillain-Barré Syndrome (GBS) continues.

• Paragonix Technologies Inc. Announces Presentation Of The Sherpapak Organ Transport Systems At American Transplant Congress (Chicago, April 29 - May 3, 2017)

  4/24/2017

• CareDx Release: Key Opinion Leaders To Present Data On Cell-Free DNA (CfDNA) Biomarker In Transplant Recipients At 2015 American Transplant Congress

  5/1/2015

• Transplant Genomics Release: Studies Presented At American Transplant Congress Describe Validation Of Noninvasive Tests For Post-Transplant Management Of Kidney Graft Recipients

  4/24/2015

• Transplant Genomics Release: Studies Presented At American Transplant Congress Describe Validation Of Noninvasive Tests For Post-Transplant Management Of Kidney Graft Recipients

  4/24/2015

• Veloxis Pharmaceuticals A/S to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress

  6/1/2012

• Bristol-Myers Squibb Company New Data on Investigational Agent Belatacept in Kidney Transplant Recipients to be Presented at 2011 American Transplant Congress

  4/25/2011

• REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress

  5/5/2010

• Alexion Pharmaceuticals Inc. Research to be Presented at the American Transplant Congress Examines the Role of Terminal Complement Inhibition in the Treatment of Kidney Transplantation Patients

  4/30/2010

• REGiMMUNE to Present Data From Preclinical Study of RGI-2001 at the 2010 American Transplant Congress

  4/28/2010

• Bristol-Myers Squibb Company Release: New Data on the Use of Investigational Agent Belatacept in Kidney Transplant Recipients to Be Presented at 2010 American Transplant Congress

  4/28/2010

• REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress

  6/1/2009

• Argos Therapeutics, Inc. Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress

  6/1/2009

• Bristol-Myers Squibb Company Release: First Phase III Data on Innovative Compound for Solid Organ Transplantation To be Featured at American Transplant Congress

  5/28/2009

• American Transplant Congress 2009: World-Class Speakers Address Congress

  5/21/2009

• REGiMMUNE to Present at the 2009 American Transplant Congress

  5/12/2009

• University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients; New Data Presented at Annual American Transplant Congress in Toronto

  6/4/2008

• Isotechnika Inc. Presents Positive Data from the Promise Trial of Voclosporin at the American Transplant Congress

  6/4/2008

• Multiple Independent Studies Report on Use of Cylex, Inc.'s Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients To Be Presented at the Annual American Transplant Congress

  6/3/2008

• Cylex, Inc. and University of Pittsburgh Medical Center Release: Cell-Mediated Immunity And Anti-HLA Antibody Tests Provide Insight To Immune Response In Renal Transplant Patients; Data Presented at American Transplant Congress

  6/2/2008